What intravenous ketorolac (Toradol) preparations are available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IV Ketorolac Preparations

Intravenous ketorolac (Toradol) is available in two concentrations: 15 mg/mL and 30 mg/mL in single-dose vials, supplied as sterile solutions containing 10% alcohol and sodium chloride. 1

Available Formulations

The FDA-approved IV ketorolac preparations include:

  • 15 mg in 1 mL (1.5% concentration)
  • 30 mg in 1 mL (3% concentration) - approved for both IV and IM use
  • 60 mg in 2 mL (3% concentration) - approved for IM administration only 1

All solutions are clear, slightly yellow in color, with a pH range of 6.9 to 7.9, adjusted with sodium hydroxide and/or hydrochloric acid. Each formulation contains 10% (w/v) alcohol USP and varying amounts of sodium chloride (6.68 mg, 4.35 mg, and 8.70 mg respectively) in sterile water. 1

Practical Considerations for Administration

The 30 mg/mL single-dose vial is the most commonly stocked preparation for IV/IM use in clinical practice. 1 This concentration allows for flexible dosing based on current evidence suggesting lower doses may be equally effective.

Compatibility and Stability

Ketorolac demonstrates excellent stability when mixed with common IV solutions including:

  • 0.9% sodium chloride
  • 5% dextrose
  • Lactated Ringer's
  • Plasma-Lyte A

The drug shows no degradation, particulate formation, or adsorption to PVC bags, glass bottles, or administration tubing for up to 48 hours at room temperature. 2 Standard admixture concentrations of 30 mg/50 mL are stable across all tested solutions.

Dosing Context

While the question asks specifically about preparations, it's clinically relevant that recent evidence supports using lower doses (10-15 mg IV) rather than the traditional 30 mg dose for acute pain management, as these provide equivalent analgesia with potentially fewer adverse effects. 3, 4 The available 30 mg/mL concentration allows for precise administration of these lower doses.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.